BlackRock Japan’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$213K Buy
2,710
+1,332
+97% +$104K ﹤0.01% 786
2016
Q3
$107K Buy
1,378
+352
+34% +$25.5K ﹤0.01% 875
2016
Q2
$71K Buy
1,026
+565
+123% +$39K ﹤0.01% 944
2016
Q1
$33K Buy
+461
New +$28.9K ﹤0.01% 1106

Other funds holding CMD

BlackRock Japan's CMD Position: Q4 2016 in Review

BlackRock Japan increased its Cantel Medical Corporation (CMD) stake by 97% in Q4 2016, buying an estimated $104K and bringing the position to 2,710 shares worth $213K. The position accounts for ﹤0.01% of the portfolio, ranked #786.

BlackRock Japan first reported a position in CMD in Q1 2016 and has held it in 4 quarters since. 234 funds tracked by Wall St. Rank hold CMD as of Q4 2016.

  • BlackRock Japan held 2,710 shares of Cantel Medical Corporation worth $213K as of Q4 2016.
  • BlackRock Japan bought 1,332 Cantel Medical Corporation shares in Q4 2016, an estimated $104K.
  • Cantel Medical Corporation made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #786 holding.
  • BlackRock Japan first reported a position in Cantel Medical Corporation in Q1 2016 and has held it in 4 quarters since.
  • 234 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.